{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:02:10Z","timestamp":1790359330039,"version":"4.1.0"},"reference-count":20,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Preeclampsia is an important cause of maternal and neonatal morbidity and mortality around the world, with hypertension on the rise in sub-Saharan Africa. First-trimester screening for preeclampsia is vital for guiding preventative therapies like low dose aspirin. Traditional biomarkers face accessibility barriers in low-resource settings. Urinary glycolic acid (GA) and methylsuccinic acid (MSA) have emerged as stable, cost-effective, non-invasive metabolic candidates. However, their prognostic value has not been systematically evaluated. This systematic review aims to evaluate the prognostic value of first trimester urinary glycolic acid and methylsuccinic acid for development of preeclampsia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This systematic review will be guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analysis \u2013 Protocols (PRISMA-P) checklist and has been registered with PROSPERO (CRD420251057596). The following databases will be searched: Cochrane Library, Embase, PubMed\/MEDLINE, Scopus, Web of Science, grey literature and trial registries from 2008 to August 2026. Eligible studies will include pregnant women in the first trimester (&lt;14 weeks) with urinary GA and\/or MSA measured, comparing those who develop preeclampsia to normotensive controls. Two independent reviewers will screen titles\/abstracts and full texts, with conflicts resolved by a third reviewer. Risk of bias will be assessed using the Quality in Prognosis Studies (QUIPS) tool. Data will be synthesized narratively: if more than 3 studies report comparable metrics, a meta-analysis using a random effects model will be performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>As a secondary analysis of peer reviewed articles, this review does not require ethical approval. Findings from the review will be disseminated through conference presentations and peer-reviewed publication.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0356735","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:44:19Z","timestamp":1790358259000},"page":"e0356735","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["First-trimester urinary glycolic acid and methylsuccinic acid measurement for preeclampsia prediction: A Systematic review protocol"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2112-1556","authenticated-orcid":true,"given":"Svitsai","family":"Chagonda","sequence":"first","affiliation":[{"name":"University of Zimbabwe Faculty of Medicine and Health Sciences","place":["Harare, Zimbabwe"],"department":["Department of Laboratory Diagnostic and Investigative Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9167-9925","authenticated-orcid":true,"given":"Vitaris","family":"Kodogo","sequence":"additional","affiliation":[{"name":"University of Zimbabwe Faculty of Medicine and Health Sciences","place":["Harare, Zimbabwe"],"department":["Department of Internal Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fortunate","family":"Katambarare","sequence":"additional","affiliation":[{"name":"University of Zimbabwe Faculty of Medicine and Health Sciences","place":["Harare, Zimbabwe"],"department":["Department of Laboratory Diagnostic and Investigative Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumbidzai","family":"Mawira","sequence":"additional","affiliation":[{"name":"University of Zimbabwe Faculty of Medicine and Health Sciences","place":["Harare, Zimbabwe"],"department":["Department of Laboratory Diagnostic and Investigative Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Marume","sequence":"additional","affiliation":[{"name":"University of Zimbabwe Faculty of Medicine and Health Sciences","place":["Harare, Zimbabwe"],"department":["Department of Laboratory Diagnostic and Investigative Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8874-907X","authenticated-orcid":true,"given":"Justen","family":"Manasa","sequence":"additional","affiliation":[{"name":"University of Zimbabwe Faculty of Medicine and Health Sciences","place":["Harare, Zimbabwe"],"department":["Department of Laboratory Diagnostic and Investigative Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Tanyanyiwa","sequence":"additional","affiliation":[{"name":"University of Zimbabwe Faculty of Medicine and Health Sciences","place":["Harare, Zimbabwe"],"department":["Department of Laboratory Diagnostic and Investigative Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Matenga","sequence":"additional","affiliation":[{"name":"University of Zimbabwe Faculty of Medicine and Health Sciences","place":["Harare, Zimbabwe"],"department":["Department of Internal Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"issue":"6","key":"pone.0356735.ref001","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"L Say","year":"2014","journal-title":"Lancet Glob Health"},{"key":"pone.0356735.ref002","doi-asserted-by":"crossref","DOI":"10.1111\/nure.12055","article-title":"Epidemiology of preeclampsia: impact of obesity","volume":"71","author":"A Jeyabalan","year":"2013","journal-title":"Nutr Rev"},{"key":"pone.0356735.ref003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.08.042","article-title":"Why is placentation abnormal in preeclampsia?","volume":"213","author":"SJ Fisher","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"pone.0356735.ref004","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/uog.14799","article-title":"Implementation of the sFlt-1\/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice","volume":"45","author":"H Stepan","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"pone.0356735.ref005","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/HYPERTENSIONAHA.116.08620","article-title":"Prediction of preeclampsia using the soluble fms-like tyrosine kinase 1 to placental growth factor ratio","volume":"69","author":"U Sovio","year":"2017","journal-title":"Hypertens Dallas Tex"},{"issue":"4","key":"pone.0356735.ref006","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-054697","article-title":"Prediction of pregnancy-related hypertensive disorders using metabolomics: a systematic review","volume":"12","author":"J Mayrink","year":"2022","journal-title":"BMJ Open"},{"key":"pone.0356735.ref007","first-page":"293271","article-title":"Oxidative Stress in Placenta: Health and Diseases","volume":"2015","author":"F Wu","year":"2015","journal-title":"Biomed Res Int"},{"issue":"7","key":"pone.0356735.ref008","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/HYPERTENSIONAHA.123.22633","article-title":"Placental methylglyoxal in preeclampsia: vascular and biomarker implications","volume":"81","author":"P Vangrieken","year":"2024","journal-title":"Hypertension"},{"issue":"3","key":"pone.0356735.ref009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0339292","article-title":"Untargeted metabolomics for the early detection of preeclampsia: A systematic review of human studies","volume":"21","author":"C Garc\u00eda-Ma\u00f1as","year":"2026","journal-title":"PLOS One"},{"key":"pone.0356735.ref010"},{"key":"pone.0356735.ref011","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"349","author":"L Shamseer","year":"2015","journal-title":"BMJ"},{"issue":"11","key":"pone.0356735.ref012","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.3390\/molecules29112530","article-title":"Advanced Mass Spectrometry-Based Biomarker Identification for Metabolomics of Diabetes Mellitus and Its Complications","volume":"29","author":"F Zhang","year":"2024","journal-title":"Molecules"},{"key":"pone.0356735.ref013"},{"key":"pone.0356735.ref014"},{"key":"pone.0356735.ref015","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2024"},{"key":"pone.0356735.ref016","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"MJ Page","year":"2021"},{"issue":"3","key":"pone.0356735.ref017","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"ML McHugh","year":"2012","journal-title":"Biochem Med (Zagreb)"},{"issue":"1","key":"pone.0356735.ref018","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12874-020-01143-3","article-title":"Development, testing and use of data extraction forms in systematic reviews: a review of methodological guidance","volume":"20","author":"RB B\u00fcchter","year":"2020","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"pone.0356735.ref019","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"JA Hayden","year":"2013","journal-title":"Ann Intern Med"},{"issue":"3","key":"pone.0356735.ref020","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/biom.12817","article-title":"Quantifying publication bias in meta-analysis","volume":"74","author":"L Lin","year":"2018","journal-title":"Biometrics"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0356735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:44:24Z","timestamp":1790358264000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0356735"}},"subtitle":[],"editor":[{"given":"Hiroyoshi","family":"Iwata","sequence":"first","affiliation":[{"name":"Hokkaido University: Hokkaido Daigaku","place":["JAPAN"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":20,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0356735","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]}}}